Auraptene in the Peels of Citrus Kawachiensis (Kawachibankan) Contributes to the Preservation of Cognitive Function: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers [0.03%]
卡氏柑橘果皮中的奥拉普坦对健康人群认知功能保护作用的随机、双盲、安慰剂对照试验
M Igase,Y Okada,M Ochi et al.
M Igase et al.
Objectives: Dementia, which is characterized by a progressive decline in cognitive function, is a major concern in aging societies. Although a number of treatments have been approved, an effective therapy to prevent the d...
Randomized Controlled Trial
The journal of prevention of Alzheimer's disease. 2018;5(3):197-201. DOI:10.14283/jpad.2017.47 2018
Detection of Rater Errors on Cognitive Instruments in a Clinical Trial Setting [0.03%]
临床试验环境下认知量表评分错误的检测方法
D J Connor,C W Jenkins,D Carpenter et al.
D J Connor et al.
Objectives: This study examines errors committed by raters in a clinical trial of a memory enhancement compound. Background: Findings o...
Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer's Disease in EXPEDITION 3 [0.03%]
EXPEDITION 3轻度阿尔茨海默病认知损害和功能损害关系分析
H Liu-Seifert,E Siemers,K Sundell et al.
H Liu-Seifert et al.
Background: Clinical progression of Alzheimer's disease is characterized by impairment in cognition and function. Objective: To assess ...
Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial [0.03%]
一项关于欧米伽-3多不饱和脂肪酸、维生素D、白藜芦醇和乳清蛋白的多元营养补充剂干预对老年人认知功能影响的6个月随机双盲对照试验
C Moran,A Scotto di Palumbo,J Bramham et al.
C Moran et al.
Objectives: To investigate the impact of a six-month multi-ingredient nutrition supplement intervention (Smartfish®), containing omega-3 polyunsaturated fatty acids (PUFAs), vitamin D, resveratrol, and whey protein, on c...
Randomized Controlled Trial
The journal of prevention of Alzheimer's disease. 2018;5(3):175-183. DOI:10.14283/jpad.2018.11 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force [0.03%]
CTAD工作组对III期EXPEDITION和EPOCH试验结果的解读与思考
P S Aisen,E Siemers,D Michelson et al.
P S Aisen et al.
Although the results were disappointing from two recent clinical trials of amyloid-targeting drugs in mild-to-moderate AD, the trials provided information that will be important for future studies, according to the EU-US CTAD Task Force, wh...
Editorial: WHO Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity: The Road for Preventing Cognitive Declines in Older Age? [0.03%]
WHO关于管理内在能力下降的社区水平干预指南：预防老年人认知衰退的道路吗？
B Vellas,D Scrase,G A Rosenberg et al.
B Vellas et al.
Editorial: Turning Point towards Blood Biomarker-Guided Targeted Therapy for Precision Medicine in Alzheimer's disease [0.03%]
编辑部：阿尔茨海默病精确诊断与治疗的转折点——以血液生物标志物为导向的靶向治疗
H Hampel,A Vergallo,U Bonuccelli et al.
H Hampel et al.